Nomination Committee of the Annual General Meeting 2024
In accordance with the resolution passed by Elekta’s Annual General Meeting on August 24, 2023, the Chairman of the Board convened the Nomination Committee for the 2024 Annual General Meeting by contacting the company’s largest shareholders in terms of votes, in addition to the shareholder or shareholders represented by the Chairman himself. The procedure is described in detail in the notice to the 2020 Annual General Meeting.
The Nomination Committee for the AGM 2024 consisted of:
- Laurent Leksell (Chair of the Nomination Committee), in his capacity as Chairman of the Board of Elekta and representing his own and related parties’ holdings
- Thomas Wuolikainen, appointed by the Fourth Swedish National Pension Fund
- Katarina Hammar, appointed by Nordea Funds
- Patrik Jönsson, appointed by SEB Funds
- Jesper Bergström, appointed by Handelsbanken
The task of the Nomination Committee is to present the following proposals for resolution:
- Chairman of the Annual General Meeting of Shareholders;
- Chairman of the Board of Directors and other members of the Board of Directors;
- fees to the Board of Directors;
- external auditor and fees to the auditor; and where deemed necessary; and
- proposal to amend the procedure for the Nomination Committee.
The Nomination Committee proposed that the Annual General Meeting 2024 reelect Laurent Leksell, who was also proposed to be reelected as Chairman of the Board, Tomas Eliasson, Caroline Leksell Cooke, Wolfgang Reim, Jan Secher, Volker Wetekam and Cecilia Wikström and elect Ann Costello and Jan Kimpen as directors of the Board. Birgitta Stymne Göransson declined reelection.
Ann Costello is a seasoned executive who brings more than 30 years of experience from the pharmaceutical and diagnostics group Roche, a world leader in diagnostics, oncology and biotechnology. From 2020 to 2023, she led Roche’s Diagnostic Solutions, its largest Diagnostics business unit with over 6,000 employees. Prior to this role, she held several executive positions within Roche in both Europe and the United States, including heading up the Pathology business unit and the Centralized Diagnostics & Point of Care Business Area. Ann Costello currently serves on the Board of Directors of Ibex AI and holds a bachelor’s degree in biomedical science from the Technological University of Dublin. She is an Irish citizen, resides in Basel, Switzerland, and was born in 1960.
Jan Kimpen is a professor of pediatrics and has extensive experience from both the hospital and academic sectors. Between 2009 and 2015, Jan Kimpen was the CEO of one of the largest hospitals in the Netherlands, University Medical Center Utrecht, with more than 10,000 employees and cancer care as one of the hospital’s focus areas. Jan Kimpen was, in 2016, recruited as Philips’ first Global Chief Medical Officer, and built a successful department during the time period up until 2023. He currently works as a strategic advisor to various companies and sits on the Board of Directors of Deerns and Twente University of Technology. Jan Kimpen was born in 1958, is a Belgian citizen and resides in Doorn, the Netherlands.
The Nomination Committee’s complete proposal was published in connection with the convening of Elekta’s Annual General Meeting 2024, held on September 5, 2024.